Kathryn Hudson
Public Communications Contact bij INDIVIOR PLC
Vermogen: 1 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Kathryn Hudson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
42
| Public Company | Pharmaceuticals: Major | 42 |
| Public Company | Home Improvement Chains | 7 | |
Indivior UK Finance Ltd.
 Indivior UK Finance Ltd. Finance/Rental/LeasingFinance Part of Indivior PLC, Indivior UK Finance Ltd. provides financing services. The private company is based in Slough, UK. Founded in 2019.
1
| Subsidiary | Finance/Rental/Leasing | 1 |
Indivior UK Finance Lending Ltd.
 Indivior UK Finance Lending Ltd. Finance/Rental/LeasingFinance Part of Indivior PLC, Indivior UK Finance Lending Ltd. operates as a financing company. The private company is based in Slough, UK.
1
| Subsidiary | Finance/Rental/Leasing | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kathryn Hudson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| ARTIVION, INC. | Medical Specialties | Compliance Officer | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| IKARIA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Conservation Education & Research Trust
 Conservation Education & Research Trust Miscellaneous Commercial ServicesCommercial Services Conservation Education & Research Trust is an organization that conducts research on environmental challenges such as biodiversity loss, freshwater pollution, and soil health. The non-profit company is based in Oxford, UK. The British company engages volunteers and corporate partners to contribute to a sustainable future through citizen science. The CEO of the company is Steve Gray. | Miscellaneous Commercial Services | Director/Board Member | |
| ADIAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director of Finance/CFO Public Communications Contact | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Leeds | College/University | Undergraduate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Graduate Degree Graduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Tennessee | College/University | Undergraduate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal President Director/Board Member General Counsel Human Resources Officer Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member | |
| R&Q INSURANCE HOLDINGS LTD. | Specialty Insurance | Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| MOELIS & COMPANY | Investment Banks/Brokers | Director/Board Member | |
Highgate LLC
 Highgate LLC Real Estate DevelopmentFinance Highgate LLC is a hospitality management and investing private company based in Birmingham, MI. Highgate LLC delivers market intelligence, scale, and technology to the hospitality industry. Highgate is known for its expertise in hotel management, investment, technology, and development, and has a diverse portfolio of hotels. The company was founded by Yvonne L. Greenstreet and Stephen R. Polk has been the CEO since 2013. | Real Estate Development | Chief Executive Officer | |
Reckitt Benckiser Health Ltd.
 Reckitt Benckiser Health Ltd. Medical DistributorsDistribution Services Founded in 2017, Reckitt Benckiser Health Ltd. is a subsidiary of Reckitt Benckiser Group Plc. The private company is based in Slough, UK. Reckitt Benckiser Health is home to the world's most loved and trusted hygiene, health, and nutrition brands. | Medical Distributors | Director/Board Member Director/Board Member | |
Sapience Therapeutics, Inc.
 Sapience Therapeutics, Inc. BiotechnologyHealth Technology Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY. | Biotechnology | Director/Board Member Chairman | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 23 |
| Verenigd Koninkrijk | 16 |
| Frankrijk | 5 |
| Ierland | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 233 |
| Corporate Officer/Principal | 97 |
| Independent Dir/Board Member | 81 |
| Chief Executive Officer | 33 |
| Chairman | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Adrian Hennah | 28 |
| Howard H. Pien | 27 |
| Euan Sutherland | 23 |
| Lizabeth Zlatkus | 23 |
| Juliet Thompson | 22 |
| Cary Claiborne | 19 |
| Peter Bains | 19 |
| Barbara Ryan | 18 |
| Mark Seligman | 18 |
| Karen Witts | 17 |
| Daniel Phelan | 17 |
| Daniel Tassé | 16 |
| Christian Schade | 16 |
| Yvonne Greenstreet | 15 |
| Rupert Bondy | 14 |
- Beurs
- Insiders
- Kathryn Hudson
- Bedrijfsconnecties
